o NoneEntity Type
0001498403
BioLineRX, Ltd.
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 BioLineRx Ltd.
Jurisdiction of Incorporation/OrganizationISRAEL 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 BioLineRx Ltd. 
Street Address 1Street Address 2
 2 HAMA'AYAN STREET 
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 MODI'IN ISRAEL 7177871 972-8-642-9100 



3. Related Persons
Last NameFirst NameMiddle Name
SchwartzAharon
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
AnghelMichaelJ.
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
BenjaminiNurit
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
BormannBarbaraJean
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
HofsteinRaphael
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
MolchoAvraham
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
PanemSandra
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
SerlinPhilipA.
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

 
Last NameFirst NameMiddle Name
ZeeviMali
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
SoraniElla
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

Last NameFirst NameMiddle Name
Vainstein-HarasAbi
Street Address 1Street Address 2
c/o BioLineRx Ltd.2 HaMa'ayan Street
CityState/Province/CountryZIP/Postal Code
Modi'inISRAEL7177871
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
 

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) x Rule 506(b)
o Rule 504 (b)(1)(ii) o Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-05-31 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests o Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities x Option, Warrant or Other Right to Acquire Another Security
x Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 H.C. Wainwright & Co., LLC 375
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 430 PARK AVENUE 3RD FLOOR
City State/Province/CountryZIP/Postal Code
 NEW YORK NEW YORK 10022
State(s) of Solicitation o All States o Foreign/Non-US
 ILLINOIS
 NEW JERSEY
 NEW YORK
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 4393000 USD o Indefinite
Total Amount Sold $ 4393000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
 The warrants and shares underlying the warrants, the subject matter of this Form D were issued in connection with an offering of (i) 2,510,286 ADSs issued in a registered direct offering, and (ii) unregistered warrants to purchase 2,510,286 ADSs.


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 5


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 307510 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
 H.C. Wainwright is also entitled to 1.0% of the gross proceeds as management fee, a $25,000 non-accountable expense reimbursement, a $35,000 accountable expense allowance and warrants to purchase 125,514 ADSs exercisable at $2.1875 per ADS for 2.5 years.


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more BioLineRx Charts.
BioLineRx (NASDAQ:BLRX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more BioLineRx Charts.
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BLRX Message Board. Create One! See More Posts on BLRX Message Board See More Message Board Posts

Biolinerx Ltd. News

Loading Messages....

More Biolinerx Ltd. News Articles